Pines Wealth Management LLC Makes New Investment in Danaher Co. (NYSE:DHR)

Pines Wealth Management LLC purchased a new position in Danaher Co. (NYSE:DHR) during the fourth quarter, Holdings Channel.com reports. The institutional investor purchased 1,048 shares of the conglomerate’s stock, valued at approximately $246,000.

A number of other institutional investors have also recently made changes to their positions in DHR. Accurate Wealth Management LLC boosted its stake in Danaher by 14.9% during the 4th quarter. Accurate Wealth Management LLC now owns 1,778 shares of the conglomerate’s stock worth $418,000 after purchasing an additional 230 shares during the last quarter. Tuttle Capital Management LLC lifted its stake in shares of Danaher by 34.6% in the fourth quarter. Tuttle Capital Management LLC now owns 1,464 shares of the conglomerate’s stock worth $336,000 after buying an additional 376 shares in the last quarter. Rosenberg Matthew Hamilton boosted its position in Danaher by 5.9% during the fourth quarter. Rosenberg Matthew Hamilton now owns 969 shares of the conglomerate’s stock worth $222,000 after acquiring an additional 54 shares during the last quarter. Ayrshire Capital Management LLC grew its stake in Danaher by 4.7% during the 4th quarter. Ayrshire Capital Management LLC now owns 31,193 shares of the conglomerate’s stock valued at $7,160,000 after acquiring an additional 1,400 shares in the last quarter. Finally, Shorepath Capital Management LLC raised its holdings in Danaher by 16.5% in the 4th quarter. Shorepath Capital Management LLC now owns 31,497 shares of the conglomerate’s stock valued at $7,230,000 after acquiring an additional 4,462 shares during the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Stock Performance

NYSE DHR opened at $237.78 on Thursday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. The company has a market cap of $171.74 billion, a P/E ratio of 45.38, a P/E/G ratio of 4.32 and a beta of 0.83. The stock has a 50-day moving average of $235.27 and a two-hundred day moving average of $253.56. Danaher Co. has a 1-year low of $222.53 and a 1-year high of $281.70.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The firm had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. During the same period in the prior year, the firm earned $2.02 EPS. The firm’s revenue for the quarter was up 3.1% on a year-over-year basis. As a group, analysts anticipate that Danaher Co. will post 7.5 EPS for the current year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be paid a dividend of $0.27 per share. The ex-dividend date is Friday, December 27th. This represents a $1.08 annualized dividend and a yield of 0.45%. Danaher’s payout ratio is 20.61%.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on DHR. Bank of America upgraded Danaher from a “neutral” rating to a “buy” rating and set a $290.00 target price on the stock in a report on Friday, December 13th. Stifel Nicolaus boosted their price objective on Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a research note on Wednesday, October 23rd. StockNews.com downgraded Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, December 14th. Scotiabank assumed coverage on shares of Danaher in a research report on Monday, December 23rd. They set a “sector perform” rating and a $265.00 price target on the stock. Finally, Barclays cut their price objective on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 23rd. Six equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and a consensus price target of $286.80.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.